HK1215200A1 - 血管栓塞系统 - Google Patents
血管栓塞系统 Download PDFInfo
- Publication number
- HK1215200A1 HK1215200A1 HK16103152.0A HK16103152A HK1215200A1 HK 1215200 A1 HK1215200 A1 HK 1215200A1 HK 16103152 A HK16103152 A HK 16103152A HK 1215200 A1 HK1215200 A1 HK 1215200A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- peptide
- systems
- methods
- amino acid
- vascular embolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K59/00—Integrated devices, or assemblies of multiple devices, comprising at least one organic light-emitting element covered by group H10K50/00
- H10K59/60—OLEDs integrated with inorganic light-sensitive elements, e.g. with inorganic solar cells or inorganic photodiodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests for contrast media
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Sustainable Development (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261726250P | 2012-11-14 | 2012-11-14 | |
| US61/726,250 | 2012-11-14 | ||
| PCT/IB2013/060145 WO2014076660A1 (en) | 2012-11-14 | 2013-11-14 | Vascular embolic system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1215200A1 true HK1215200A1 (zh) | 2016-08-19 |
Family
ID=49725176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16103152.0A HK1215200A1 (zh) | 2012-11-14 | 2013-11-14 | 血管栓塞系统 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US20160287744A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2919826B1 (cg-RX-API-DMAC7.html) |
| JP (6) | JP2016501066A (cg-RX-API-DMAC7.html) |
| HK (1) | HK1215200A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014076660A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| US10235906B2 (en) | 2014-11-18 | 2019-03-19 | Maximum Fidelity Surgical Simulations, LLC | Post mortem reconstitution of circulation |
| WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| CN109195640A (zh) * | 2016-03-18 | 2019-01-11 | 立美基股份有限公司 | 脑脊液漏堵塞 |
| US20190091376A1 (en) * | 2016-03-18 | 2019-03-28 | 3-D Matrix, Ltd. | Preventing Biological Tissue Adhesion |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| PE20200719A1 (es) | 2017-11-13 | 2020-07-21 | Maximum Fidelity Surgical Simulations Llc | Reconstitucion de la circulacion posmortem, metodos y procedimientos especializados |
| US11716989B2 (en) | 2019-04-16 | 2023-08-08 | Maximum Fidelity Surgical Simulations, LLC | Cadaver preservation systems and methods |
| US11915610B2 (en) | 2019-05-15 | 2024-02-27 | Maximum Fidelity Surgical Simulations, LLC | Cadaverous heart model |
| CN115397454A (zh) | 2020-03-31 | 2022-11-25 | 立美基股份有限公司 | 通过辐照对自组装肽进行灭菌 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10127754A (ja) * | 1996-11-06 | 1998-05-19 | Koken Co Ltd | コラーゲンからなる塞栓材 |
| DK1355566T3 (da) * | 2000-12-18 | 2013-03-04 | Univ Texas | Lokal regional kemoterapi og radioterapi ved anvendelse af hydrogel in situ |
| US7449180B2 (en) | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| US7179784B2 (en) | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| US7713923B2 (en) | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| CA2572964C (en) | 2004-07-06 | 2018-03-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US7790699B2 (en) * | 2004-10-12 | 2010-09-07 | Fmc Biopolymer As | Self-gelling alginate systems and uses thereof |
| GB0500643D0 (en) | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
| KR20100102750A (ko) | 2005-04-25 | 2010-09-24 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법 |
| US8299032B2 (en) | 2005-06-27 | 2012-10-30 | Menicon Co., Ltd. | Self-assembling peptide and gel produced from the same |
| JP5121172B2 (ja) | 2005-07-01 | 2013-01-16 | 日本合成化学工業株式会社 | 血管一時塞栓材料、その製造方法、および血管一時塞栓剤 |
| US8361454B2 (en) | 2005-07-01 | 2013-01-29 | The Nippon Synthetic Chemical Industry Co., Ltd. | PVA particle for temporary embolic material and production process thereof, and temporary embolic material |
| JP5263756B2 (ja) | 2005-09-30 | 2013-08-14 | 国立大学法人 岡山大学 | 細胞の培養方法および細胞培養物 |
| HUE037994T2 (hu) | 2006-04-25 | 2018-09-28 | Massachusetts Inst Technology | Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására |
| EP2066697A2 (en) | 2006-09-26 | 2009-06-10 | Massachusetts Institute of Technology | Modified self-assembling peptides |
| JP5558104B2 (ja) | 2006-12-11 | 2014-07-23 | スリー−ディー マトリックス, インコーポレイテッド | 心組織の保護および再生のための組成物および方法 |
| US9415084B2 (en) | 2007-03-14 | 2016-08-16 | Arch Biosurgery, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| US9987221B2 (en) * | 2007-08-23 | 2018-06-05 | Boston Scientific Scimed, Inc. | Injectable hydrogel compositions |
| ES2534770T3 (es) | 2007-12-05 | 2015-04-28 | 3-D Matrix, Ltd. | Material para la curación de heridas y la reconstrucción de la piel |
| JP4422191B1 (ja) | 2008-09-30 | 2010-02-24 | ゼライス株式会社 | 架橋ゼラチン、塞栓剤および架橋ゼラチンの製造方法 |
| CN105435211A (zh) * | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| US8962784B2 (en) | 2008-12-19 | 2015-02-24 | Ethicon, Inc. | Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant |
| JP2012100680A (ja) * | 2009-03-04 | 2012-05-31 | Terumo Corp | 血管内用処置材 |
| WO2010103887A1 (ja) | 2009-03-09 | 2010-09-16 | 株式会社メニコン | 自己組織化ペプチドおよび高強度ペプチドゲル |
| KR101764439B1 (ko) | 2009-04-22 | 2017-08-02 | 머케이터 메드시스템즈, 인크. | 국소 혈관 운반으로 고혈압을 치료하는 구아네티딘의 용도 |
| US20120123355A1 (en) * | 2009-07-30 | 2012-05-17 | Cook Medical Technologied | Erodible embolization material |
| US20110117195A1 (en) * | 2009-11-18 | 2011-05-19 | National Cheng Kung University | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| EP2351779B1 (en) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microspheres and method of making the microspheres |
| US8741833B2 (en) | 2010-07-16 | 2014-06-03 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| WO2012133608A1 (ja) * | 2011-03-30 | 2012-10-04 | 東レ株式会社 | 生分解性粒子、血管塞栓材料及び生分解性粒子の製造方法 |
| JP6034868B2 (ja) | 2011-09-02 | 2016-11-30 | 株式会社スリー・ディー・マトリックス | 胸部の空気漏れ閉塞のための両親媒性ペプチド |
| US20150105336A1 (en) | 2012-03-09 | 2015-04-16 | 3-D Matrix, Ltd. | Mucosa-elevating agent |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| HK1220116A1 (zh) | 2013-03-06 | 2017-04-28 | 3-D Matrix Ltd. | 使用纯化的两亲性多肽组合物的外科手术方法 |
| WO2014141160A1 (en) | 2013-03-14 | 2014-09-18 | 3-D Matrix, Ltd | Treatment for bile leakage |
| CA2905182A1 (en) | 2013-03-14 | 2014-09-18 | 3-D Matrix, Ltd. | Materials for gastrointestinal obstruction prevention |
| WO2015027203A1 (en) | 2013-08-22 | 2015-02-26 | Arch Biosurgery, Inc. | Implantable meshes for controlling the movement of fluids |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| WO2015138475A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Self-assembling peptides as bronchial obstruction agents |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| JP2017513927A (ja) | 2014-03-10 | 2017-06-01 | 株式会社スリー・ディー・マトリックス | 肺の漏出を治療するための自発組織化ペプチド |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| JP2017519568A (ja) | 2014-06-20 | 2017-07-20 | 株式会社スリー・ディー・マトリックス | 骨間隙を充填するための材料および方法 |
| BR112016029517A2 (pt) | 2014-06-20 | 2018-06-19 | 3 D Matrix Ltd | materiais e métodos para enchimento de vácuo do osso dentário |
| WO2016075977A1 (ja) | 2014-11-14 | 2016-05-19 | 株式会社スリー・ディー・マトリックス | 自己組織化ペプチド修飾キトサンナノ会合体の合成とプロテインデリバリーへの応用 |
| EP3262155A1 (en) | 2015-02-25 | 2018-01-03 | 3-D Matrix, Ltd | Synthetic peptide hydrogel formulations for use as extracellular matrix |
-
2013
- 2013-11-14 US US14/442,677 patent/US20160287744A1/en not_active Abandoned
- 2013-11-14 HK HK16103152.0A patent/HK1215200A1/zh unknown
- 2013-11-14 JP JP2015542401A patent/JP2016501066A/ja active Pending
- 2013-11-14 WO PCT/IB2013/060145 patent/WO2014076660A1/en not_active Ceased
- 2013-11-14 EP EP13802115.9A patent/EP2919826B1/en active Active
-
2018
- 2018-02-26 JP JP2018032093A patent/JP2018086425A/ja active Pending
-
2019
- 2019-05-14 JP JP2019091205A patent/JP2019122875A/ja active Pending
-
2021
- 2021-07-09 JP JP2021114234A patent/JP2021164739A/ja not_active Withdrawn
- 2021-11-24 US US17/535,470 patent/US20220168462A1/en not_active Abandoned
-
2023
- 2023-06-23 JP JP2023103314A patent/JP2023115128A/ja active Pending
-
2024
- 2024-12-26 JP JP2024231414A patent/JP2025031996A/ja active Pending
-
2025
- 2025-06-12 US US19/235,902 patent/US12629446B2/en active Active
-
2026
- 2026-03-26 US US19/629,304 patent/US20260199545A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025031996A (ja) | 2025-03-07 |
| US20260199545A1 (en) | 2026-07-16 |
| JP2016501066A (ja) | 2016-01-18 |
| JP2018086425A (ja) | 2018-06-07 |
| WO2014076660A1 (en) | 2014-05-22 |
| JP2019122875A (ja) | 2019-07-25 |
| EP2919826A1 (en) | 2015-09-23 |
| US12629446B2 (en) | 2026-05-19 |
| US20160287744A1 (en) | 2016-10-06 |
| US20220168462A1 (en) | 2022-06-02 |
| EP2919826B1 (en) | 2025-06-11 |
| US20250311587A1 (en) | 2025-10-02 |
| JP2021164739A (ja) | 2021-10-14 |
| JP2023115128A (ja) | 2023-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015056237A3 (en) | Purification of proteins | |
| HK1211468A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
| WO2012125987A3 (en) | Delivery system | |
| HK1206370A1 (en) | Charged nutritive proteins and methods | |
| CA2883095C (en) | Antibody and protein formulations | |
| WO2013096838A3 (en) | Systems and methods for isolating nucleic acids | |
| WO2013084000A3 (en) | Exosomes for delivery of biotherapeutics | |
| EP3274459A4 (en) | Platform for non-natural amino acid incorporation into proteins | |
| WO2014028493A3 (en) | Exosomes and micro-ribonucleic acids for tissue regeneration | |
| WO2014160490A8 (en) | Antibody formulations | |
| WO2011112856A3 (en) | Novel protein peptide hydrogels | |
| BR112017011531A2 (pt) | microesfera, métodos para preparar um sal de conjugado de proteína-peg e um conjugado de proteína-peg com hidrofobicidade aumentada, para preparar microesferas de liberação controlada e para preparar uma solução ou suspensão de um polímero biodegradável e de um sal de conjugado de proteína-peg, e, composição. | |
| HK1206764A1 (en) | Nutritive proteins and methods | |
| WO2012158964A3 (en) | Improved peptide pharmaceuticals for osteoporosis | |
| WO2013098755A3 (en) | Anticancer fusion protein | |
| HK1206763A1 (en) | Charged nutritive fragments, proteins and methods | |
| MX387764B (es) | Procedimiento de disminucion de la inmunogenicidad de proteinas y peptidos. | |
| MX354156B (es) | Dipeptido que comprende un aminoacido no proteogenico. | |
| WO2012151328A3 (en) | Spatial sequestration of dynamic nucleic acid circuits | |
| EP4653537A3 (en) | Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function | |
| WO2013111012A3 (en) | Methods and compositions for therapeutic agents | |
| WO2012040406A3 (en) | Human-adapted ha polypeptides, vaccines, and influenza treatment | |
| WO2016014595A3 (en) | Antibodies that recognize red blood cell antigens | |
| WO2013040478A3 (en) | Hyr1-derived compositions and methods of treatment using same | |
| WO2012122378A3 (en) | Antibody-like proteins for therapeutic and diagnostic use |